RCANCRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。RCAN遺伝子サイレンサーは、RCAN CRISPR/Cas9ノックアウトプラスミドとRCANDouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のRCANCRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
RCAN CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
RCAN2 CRISPR/Cas9 KOプラスミド (h) | sc-417136 | h | Gene Knockout | GFP | 0 | ||
RCAN2 HDRプラスミド (h) | sc-417136-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
RCAN2 Double Nickaseプラスミド (h) | sc-417136-NIC | h | Gene Knockout | Puromycin | 0 | ||
RCAN2 Double Nickaseプラスミド (h2) | sc-417136-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
RCAN2 CRISPR/Cas9 KOプラスミド (m) | sc-424772 | m | Gene Knockout | GFP | 0 | ||
RCAN2 HDRプラスミド (m) | sc-424772-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
RCAN2 Double Nickaseプラスミド (m) | sc-424772-NIC | m | Gene Knockout | Puromycin | 0 | ||
RCAN2 Double Nickaseプラスミド (m2) | sc-424772-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
RCAN3 CRISPR/Cas9 KOプラスミド (h) | sc-416609 | h | Gene Knockout | GFP | 0 | ||
RCAN3 HDRプラスミド (h) | sc-416609-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
RCAN3 Double Nickaseプラスミド (h) | sc-416609-NIC | h | Gene Knockout | Puromycin | 0 | ||
RCAN3 Double Nickaseプラスミド (h2) | sc-416609-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
RCAN3 CRISPR/Cas9 KOプラスミド (m) | sc-424773 | m | Gene Knockout | GFP | 0 | ||
RCAN3 HDRプラスミド (m) | sc-424773-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
RCAN3 Double Nickaseプラスミド (m) | sc-424773-NIC | m | Gene Knockout | Puromycin | 0 | ||
RCAN3 Double Nickaseプラスミド (m2) | sc-424773-NIC-2 | m | Gene Knockout | Puromycin | 0 |
RCAN CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
RCAN2 CRISPR Activationプラスミド (h) | sc-417136-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RCAN2 CRISPR Activationプラスミド (h2) | sc-417136-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RCAN2 Lentiviral Activation Particles (h) | sc-417136-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RCAN2 Lentiviral Activation Particles (h2) | sc-417136-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RCAN2 CRISPR Activationプラスミド (m) | sc-424772-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RCAN2 CRISPR Activationプラスミド (m2) | sc-424772-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RCAN2 Lentiviral Activation Particles (m) | sc-424772-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RCAN2 Lentiviral Activation Particles (m2) | sc-424772-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RCAN3 CRISPR Activationプラスミド (h) | sc-416609-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RCAN3 CRISPR Activationプラスミド (h2) | sc-416609-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RCAN3 Lentiviral Activation Particles (h) | sc-416609-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RCAN3 Lentiviral Activation Particles (h2) | sc-416609-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RCAN3 CRISPR Activationプラスミド (m) | sc-424773-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RCAN3 CRISPR Activationプラスミド (m2) | sc-424773-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RCAN3 Lentiviral Activation Particles (m) | sc-424773-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RCAN3 Lentiviral Activation Particles (m2) | sc-424773-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |